Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 16 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (7)
P 2 (1)
P 4 (1)

Trial Status

Completed11
Recruiting3
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
Showing all 16 trials

Research Network

Activity Timeline